Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report)’s share price shot up 1.6% during trading on Wednesday . The company traded as high as $6.10 and last traded at $6.10. 200 shares traded hands during mid-day trading, a decline of 87% from the average session volume of 1,595 shares. The stock had previously closed at $6.00.
Silence Therapeutics Price Performance
The business’s 50 day moving average is $6.18 and its 200 day moving average is $6.96.
Silence Therapeutics Company Profile
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company's mRNAi GalNAc Oligonucleotide Discovery platform consists of precision engineered product candidates designed to target specific disease-associated genes in the liver.
See Also
- Five stocks we like better than Silence Therapeutics
- What is a Low P/E Ratio and What Does it Tell Investors?
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- 3 Monster Growth Stocks to Buy Now
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- Dividend Capture Strategy: What You Need to Know
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
